Share

September 01, 2020; 95 (9) Article

Blood biomarkers of traumatic brain injury and cognitive impairment in older veterans

Carrie B. Peltz, Kimbra Kenney, Jessica Gill, Ramon Diaz-Arrastia, Raquel C. Gardner, Kristine Yaffe
First published June 22, 2020, DOI: https://doi.org/10.1212/WNL.0000000000010087
Full PDF
Short Form
Citation
Permissions

Make Comment

See Comments

Downloads
0

Share

Article Information

vol. 95 no. 9 e1126-e1133
DOI: 
https://doi.org/10.1212/WNL.0000000000010087
PubMed: 
32571850
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received September 30, 2019
  • Accepted in final form February 27, 2020
  • First Published June 22, 2020.

Article Versions

Copyright & Usage: 
© 2020 American Academy of Neurology

Author Disclosures

    1. Carrie B. Peltz, PhD,
    2. Kimbra Kenney, MD,
    3. Jessica Gill, PhD,
    4. Ramon Diaz-Arrastia, MD, PhD,
    5. Raquel C. Gardner, MD and
    6. Kristine Yaffe, MD
  1. Carrie B. Peltz, PhD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1. DOD W81XWH-14-2-0137, Study Coordinator, 2014-current 2. DOD, W81XWh-14-1-0467, Study Coordinator, 2014-current

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Kimbra Kenney, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Jessica Gill, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH intramural research, year 2012-current

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Ramon Diaz-Arrastia, MD, PhD,
    5. Scientific Advisory Boards:

    1. NeuralAnalytics, Inc BrainBox Solutions, Inc FloTBI Pinteon Therapeutics MesoScale Discoveries

    Gifts:

    1. BrainBox Solutions, Inc. Pinteon Therapeutics

    Funding for travel or speaker honoraria:

    1. Quanterix, Inc

    Editorial Boards:

    1. Journal of Neurotrauma Frontiers of Neuroscience

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. BrainBox Solutions, Inc

    Research Support, Government Entities:

    1. NIH/NINDS U01 NS086090 09/01/2013-08/30/2018 co-PI NIH/NINDS Project Title: “Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK TBI)” DoD/USAMRAA Diaz-Arrastia (Co-PI) (Manley-PI) 09/01/2014- 08/31/2018 Project Title: “TBI Endpoints Development (TED)” NIH/NINDS U01 NS099046 (Diaz-Arrastiaco-PI) 8/1/2018 – 7/31/2023 2.4 $32,532,017 Project Title: Brain Oxygen Optimization in Severe TBI—Phase 3 (BOOST-3) NIH/NINDS U24 NS107199 (R. Diaz-Arrastia, contact PI) 9/1/2018 – 8/31/2023 Project title: Penn Center for Excellence in Neuroscience Clinical Trials (Penn NeuroNEXT) NIH/NINDS U01 NS114140 (R.Diaz-Arrastia, PI) 12/1/2019 – 11/30/2024 Project Title: Clinical validation of serum neurofilament light as a biomarker of traumatic axonal injury US Dept. of Defense BA170613 (R. Diaz-Arrastia, PI) 9/1/2019 – 8/30/2023 Project Title: Biomarkers of Brain Oxygen Optimization in Severe TBI Trial (Bio-BOOST) US Department of Defense EP180013 (R. Diaz-Arrastia, PI) 9/1/2019 – 8/30/2023 Project Title: TRACK-TBI Epileptogenesis Project

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. Neural Analytics, Inc BrainBox Solutions, Inc Stock/Stock Options, Medical Equipment & Materials: Neural Analytics, Inc

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Raquel C. Gardner, MD and
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) NIH, reimbursement for travel to a conference at NIH in 2019

    Editorial Boards:

    1. 2017-present: PLOS Medicine, Academic Editor

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NINDS, Beeson K23 NS095755, PI, 2015-2020 NINDS, R01 NS110944, PI, 2019-2024 Department of Defense, W81XWH-18-1-0514, PI, 2018-2021 Department of Defense, W81XWH-18-PRARP-RPA, multi-PI, 2019- 2022

    Research Support, Academic Entities:

    1. (1) UCSF Pepper Center Research Career Development Core (2) UCSF Research Allocation Program (3) UCSF Weill Institute for Neuroscience

    Research Support, Foundations and Societies:

    1. (1) American Federation for Aging Research (2) Global Brain Health Institute

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Kristine Yaffe, MD
    7. Scientific Advisory Boards:

    1. 1)DSMB for Eli Lilly 2)DSMB for NIH sponsored study 3)Beeson Scientific Advisory Board 4)Global Council on Brain Health Governance Committee 5)Board member of Alector

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. -Associate Editor, 2011-, International Review of Psychiatry -Editorial Board Member 2014-, Journal of Prevention of Alzheimer’s Disease - Editorial Board Member 2017-, Alzheimer’s & Dementia: Translational Research & Clinical Interventions - Editorial Board Member 2018-, Translational Neurodegeneration

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1. K24 AG031155 (PI) NIA Predictors of cognitive aging across the lifecourse 06/13-11/20 2. Director Sierra-Pacific VISN Mental Illness Research, Educational and Clinical Center Psychiatric Fellowship 10/09-09/23 3. PI of Dementia Research at SF VA Medical Center Sierra-Pacific VISN Mental Illness Research, Educational and Clinical Center 10/09-09/23 4. (Co-Investigator, PI: Cifu) Department of Defense/VA Chronic Effects of Neurotrauma Consortium (Military and Veterans Rehabilitation and Recovery from Injury Network) 07/13-09/19 5. W81XWH-14-2-0137 (PI: Yaffe) Department of Defense Blood biomarker profile of TBI-associated cognitive impairment among old & young veterans 10/14-09/19 6. W81XWH-14-2-0176 (Co-Investigator, PI: Manley) Department of Defense Traumatic Brain Injury Endpoints Development (TED) Award 10/14-09/19 7. R01 HL122658 (Multiple PI: Yaffe and Sidney) NHLBI Determinants of Midlife & Longitudinal Change in Cognitive Function 12/14-11/19 8. W81XWH-12-PHTBI-CENC (PI: Yaffe) Department of Defense/VA Epidemiology Project. Chronic Effects of Neurotrauma Consortium (Military and Veterans Rehabilitation and Recovery from Injury Network) 02/15-09/19 9. R01 AG048234 (Co-investigator, PI: Kramer) NIA Effects of Chronic Inflammation on Brain Structure and Function 04/15-01/20 10. R01 AG032289 (Co-investigator, PI: Kramer) NIA Biological predictors of brain aging trajectories 09/15-05/20 11. R01 AG052964 (Co-investigator, PI: Cummings) NIA Comprehensive Evaluation of Aging-Related Clinical Outcomes and Geroproteins 06/16-05/21 12. RF1 G050745 (Co-investigator, PI: Spira) NIA The ARIC study of midlife sleep and late-life brain amyloid 06/16-05/21 13. UL1 TR991872 (Director of Pilot Grants Program, PI: Grandis) National Center for Advancing Translational Sciences Clinical and Translational Science Institute 07/16-06/21 14. W81XWH-16-1-0507 (PI: Yaffe) Department of Defense Risk and Resiliency for Dementia: Comparison of Male and Female Veterans 08/16-08/19 15. RF1 AG054443 (Multiple PI: Yaffe and Zeki-Al Hazzouri) NIA Healthy Heart, Healthy Brain? A Pooled Life-course Cohort for Dementia Risk Assessment 05/17-04/21 16. R01 AG054073 (Multiple PI: Yaffe/O’Bryant/Toga) NIA Health Disparities in Alzheimer’s Disease and Mild Cognitive Impairment among Mexican Americans 09/17-05/22 17. R01 AG057508 (Multiple PI: Yaffe/Larson) NIA Systematic Multi-Domain Alzheimer’s Risk Reduction Trial 09/17-05/21 18. R13 AG058415 (Multiple PI: Yaffe/Gill) American Federation for Aging Research Paul B Beeson Emerging Leaders Career Development Awards in Aging Annual Meeting 09/17-05/22 19. R01 AG058537 (Multiple PI: Yaffe/O’Bryant) NIA An Alzheimer’s Blood Test for Primary Care 6/18-5/21 20. P30 AG044281 (Co-Investigator, PI: Covinsky) NIA UCSF Older American Independence Center 07/18-06/23 21. W81XWH-18-1-0692 (Multiple PI: Yaffe/Plassman) Department of Army Genetics, comorbidities, and ethnicity: Effects of TBI on Dementia 9/18-09/21 22. P30 AG062422 (REC Core PI and Data Core Co- Investigator; PI: Miller) NIH New Approaches to Dementia Heterogeneity (Alzheimer’s Disease Research Centers) 04/19-03/24

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. 1)Doris Duke Charitable Foundation Doris Duke Fund to Retain Clinical Scientists 2) Alzheimer’s Drug Discovery Foundation Connection Between Depressive Symptoms and Dementia:When Best to Intervene? 3)2018-A-006-NET (Co-Investigator, PI: Kramer) Larry L. Hillblom Foundation Hillblom Network for the Prevention of Age-Associated Cognitive Decline

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From San Francisco Veterans Affairs Health Care System (C.B.P., R.C.G., K.Y.), CA; Northern California Institute for Research and Education (C.B.P.), San Francisco; Uniformed Services University of the Health Sciences (K.K.), Rockville; NIH (J.G.), Bethesda, MD; Department of Neurology (R.D.-A.), University of Pennsylvania, Philadelphia; and Departments of Neurology (R.C.G., K.Y.), Psychiatry (K.Y.), and Epidemiology and Biostatistics (K.Y.), University of California, San Francisco.
  1. Correspondence
    Dr. Peltz carrie.peltz{at}ncire.org
View Full Text

Article usage

Article usage: June 2020 to April 2023

AbstractFullPdfSource
Jun 2020518023Highwire
Jul 2020449014Highwire
Aug 20204619020Highwire
Sep 2020100112459Highwire
Oct 20201205723Highwire
Nov 20202411613Highwire
Dec 202016767Highwire
Jan 202121277Highwire
Feb 202118176Highwire
Mar 202120668Highwire
Apr 202125266Highwire
May 202122067Highwire
Jun 202119365Highwire
Jul 202119694Highwire
Aug 202114297Highwire
Sep 202115556Highwire
Oct 202117167Highwire
Nov 202114453Highwire
Dec 202114151Highwire
Jan 202213294Highwire
Feb 202214696Highwire
Mar 202211943Highwire
Apr 202222833Highwire
May 202212324Highwire
Jun 202210853Highwire
Jul 202211846Highwire
Aug 202212010Highwire
Sep 202218820Highwire
Oct 202213193Highwire
Nov 202215357Highwire
Dec 20229632Highwire
Jan 202314311Highwire
Feb 202312454Highwire
Mar 202315211Highwire
Apr 20235812Highwire

Cited By...

Letters: Rapid online correspondence

Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles